Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Aptose Biosciences Inc Business Update Call Transcript

Jun 11, 2021 / 12:00PM GMT
Release Date Price: $56.4 (-32.01%)
Operator

Greetings, and welcome to the Aptose Biosciences' Corporate Update Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Dan Ferry of LifeSci Advisors. Thank you. You may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator. Good morning, and welcome to the Aptose Biosciences' Corporate Update in Concurrence with the 2021 EHA Conference. I am Dan Ferry, an Investor Relations representative for Aptose Biosciences.

Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Dr. Jotin Marango, Senior Vice President, Chief Financial Officer and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer.

I would now like to hand the call over to Dr. Rice. Dr. Rice, the floor is yours.

William G. Rice
Aptose Biosciences Inc. - Chairman, President & CEO

Thank you, Dan, and a good morning and warm thanks to all of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot